[Form 4] GeneDx Holdings Corp. Insider Trading Activity
Rhea-AI Filing Summary
Ryan Jason, a director of GeneDx Holdings Corp. (WGS), reported multiple open-market dispositions of Class A common stock on 08/27/2025. The Form 4 records seven separate sales totaling 39,222 shares (8,818; 8,969; 5,443; 3,452; 9,890; 1,500; 1,150) at weighted-average prices ranging roughly from $124.50 to $130.19 per share. After these transactions, the filing shows beneficial ownership positions reported as indirect through the "Jason Ryan 2024 GRAT," with the largest reported post-transaction position at 132,538 shares and the smallest at 11,904 shares; one line shows 103,284 shares directly or indirectly owned. The filing discloses that Jason Ryan is trustee and sole annuitant of the GRAT and remains the beneficial owner of securities held by the trust.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director executed multiple weighted-average share sales while retaining beneficial ownership via a GRAT; disclosure is compliant and detailed.
The Form 4 provides clear, transaction-level disclosure of seven dispositions on 08/27/2025, including weighted-average prices and post-transaction beneficial ownership counts. The reporting person identifies the Jason Ryan 2024 GRAT and confirms continued beneficial ownership through that trust, which clarifies indirect ownership relationships for governance transparency. For boards and compliance officers, the filing demonstrates adherence to Section 16 reporting requirements and includes footnotes offering price ranges per tranche, enabling precise review if requested by regulators or shareholders.
TL;DR: Substantial insider sales (39,222 shares) disclosed with price ranges; impact appears informational rather than clearly material.
The schedule of sales lists aggregate dispositions across seven entries totaling 39,222 Class A shares with weighted-average prices from approximately $124.50 to $130.19. Post-transaction beneficial ownership figures are provided per line, including 132,538, 123,569, 118,126, 114,674, 104,784, 103,284, and 11,904. The analyst note is factual: the filing supplies granular sale information and confirms that the reporter is trustee and sole annuitant of the GRAT, maintaining beneficial ownership through the trust vehicle.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 8,818 | $125.0729 | $1.10M |
| Sale | Class A Common Stock | 8,969 | $126.1536 | $1.13M |
| Sale | Class A Common Stock | 5,443 | $127.4373 | $694K |
| Sale | Class A Common Stock | 3,452 | $128.0408 | $442K |
| Sale | Class A Common Stock | 9,890 | $129.5945 | $1.28M |
| Sale | Class A Common Stock | 1,500 | $130.0103 | $195K |
| Sale | Class A Common Stock | 1,150 | $129.6461 | $149K |
Footnotes (1)
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.50 to $125.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person is the trustee of the Jason Ryan 2024 GRAT Trust U/A DTD 11/7/2024 (the "GRAT"), and the reporting person is the sole annuitant of the GRAT. The reporting person remains the beneficial owner of the securities held by the GRAT. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.655 to $126.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.76 to $127.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.76 to $128.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.89 to $129.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.91 to $130.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.50 to $129.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
